[HTML][HTML] Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitis

P Ge, Y Luo, CS Okoye, H Chen, J Liu, G Zhang… - Biomedicine & …, 2020 - Elsevier
Severe acute pancreatitis (SAP), a serious inflammatory disease of the pancreas, can easily
lead to systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction …

[HTML][HTML] The Impact of PM2.5 on the Host Defense of Respiratory System

L Yang, C Li, X Tang - Frontiers in cell and developmental biology, 2020 - frontiersin.org
The harm of fine particulate matter (PM2. 5) to public health is the focus of attention around
the world. The Global Burden of Disease (GBD) Study 2015 ranked PM2. 5 as the fifth …

Effects of dietary components on intestinal permeability in health and disease

K Khoshbin, M Camilleri - American Journal of Physiology …, 2020 - journals.physiology.org
Altered intestinal permeability plays a role in many pathological conditions. Intestinal
permeability is a component of the intestinal barrier. This barrier is a dynamic interface …

[HTML][HTML] Target specific tight junction modulators

J Brunner, S Ragupathy, G Borchard - Advanced drug delivery reviews, 2021 - Elsevier
Intercellular tight junctions represent a formidable barrier against paracellular drug
absorption at epithelia (eg, nasal, intestinal) and the endothelium (eg, blood–brain barrier) …

[HTML][HTML] Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19

C Tindle, MK Fuller, A Fonseca, S Taheri… - Elife, 2021 - elifesciences.org
Background: SARS-CoV-2, the virus responsible for COVID-19, causes widespread damage
in the lungs in the setting of an overzealous immune response whose origin remains …

Engineering the drug carrier biointerface to overcome biological barriers to drug delivery

JA Finbloom, F Sousa, MM Stevens… - Advanced drug delivery …, 2020 - Elsevier
Micro and nanoscale drug carriers must navigate through a plethora of dynamic biological
systems prior to reaching their tissue or disease targets. The biological obstacles to drug …

[HTML][HTML] Tight junctions in pulmonary epithelia during lung inflammation

OH Wittekindt - Pflügers Archiv-European Journal of Physiology, 2017 - Springer
Inflammatory lung diseases like asthma bronchiale, chronic obstructive pulmonary disease
and allergic airway inflammation are widespread public diseases that constitute an …

[HTML][HTML] Medium throughput breathing human primary cell alveolus-on-chip model

JD Stucki, N Hobi, A Galimov, AO Stucki… - Scientific reports, 2018 - nature.com
Organs-on-chips have the potential to improve drug development efficiency and decrease
the need for animal testing. For the successful integration of these devices in research and …

[HTML][HTML] Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome

JA Englert, C Bobba, RM Baron - JCI insight, 2019 - ncbi.nlm.nih.gov
Sepsis-induced acute respiratory distress syndrome (ARDS) has high morbidity and
mortality and arises after lung infection or infection at extrapulmonary sites. An aberrant host …

Cell-cell junctions: structure and regulation in physiology and pathology

MS Adil, SP Narayanan, PR Somanath - Tissue Barriers, 2021 - Taylor & Francis
Epithelial and endothelial cell-cell contacts are established and maintained by several
intercellular junctional complexes. These structurally and biochemically differentiated …